NCT07129096

Brief Summary

Temporomandibular disorders (TMD) are common musculoskeletal pain conditions related to masticatory muscles and temporomandibular joints. Applied relaxation (AR) is a self-management method widely used and tested for treatment of various psychological and somatic conditions, including musculoskeletal pain and other chronic pain conditions. AR is trained step-by-step on a 6-week program under guidance of health care professional. For training of AR, a web application (Relappy) has been developed in University of Oulu, Finland. The aim of the project is to test the Relappy for training of AR. At first, Relappy is tested by volunteers (n=26). The randomized controlled trial on TMD patients evaluates the effectiveness of web application-based AR training on TMD pain symptoms, psychosocial burden, sleep quality and autonomic nervous system (ANS) activity. The study sample includes TMD patients (n=124) from Finnish Student Health Service in Oulu and Turku units. They are randomly assigned to 2 treatment groups: AR group (trained by AR web application) and stabilization splint group (traditional treatment). TMD pain, body pain, psychosocial symptoms and sleep problems are assessed with validated questionnaires at baseline and at 6-week, 3- month and 1-year follow-up points. The patients also use a digital sleep diary application. Additionally, ANS activity is measured from patients in Oulu before treatment and 3 months weeks and 1 year after baseline. In the analyses, the variables are compared between treatment groups. The present project also includes preparing of the commercialization, aiming to develop the Relappy for wider target groups of pain patients and public use, regardless of time and place of use. The project has many societal and economic impacts. It can be expected that when actively trained, web application for AR will offer a cost-efficient self-management method to relieve TMD pain, body pain, and other stress-related symptoms and thus improve general well-being. It is expected to reduce healthcare costs and treatment burden and promote sustainability.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
124

participants targeted

Target at P50-P75 for not_applicable

Timeline
57mo left

Started Jan 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress33%
Jan 2024Dec 2030

Study Start

First participant enrolled

January 8, 2024

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

June 19, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 19, 2025

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

Expected
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2030

Last Updated

September 11, 2025

Status Verified

September 1, 2025

Enrollment Period

4.9 years

First QC Date

June 19, 2025

Last Update Submit

September 4, 2025

Conditions

Keywords

randomized controlled trial

Outcome Measures

Primary Outcomes (2)

  • TMD pain-related intensity

    The patient fill in a webropol-based questionnaire on Graded Chronic Pain Scale (GCPS2.0) included in the validated Diagnostic Criteria for Temporomandibular Disorders (DC/TMD). The data is collected at baseline and at the 6-week, 3-month and 1-year follow-up points (after beginning the treatment). Mean pain-related intensity is mean of current, worst and average intensity of pain (on a scale from 0 (no pain) to 10 (worst pain).

    from baseline until 1 year from baseline

  • TMD pain-related interference

    The patient fill in a webropol-based questionnaire on Graded Chronic Pain Scale (GCPS2.0) included in the validated Diagnostic Criteria for Temporomandibular Disorders (DC/TMD). The data is collected at baseline and at the 6-week, 3-month and 1-year follow-up points (after beginning the treatment). The mean pain-related interference (during preceding 30 days) is calculated as mean of interference on daily activities, social activities and ability to work, using a scale from 0 (no interference) to 10 (unable to carry on any activities).

    from baseline until 1 year from baseline

Secondary Outcomes (9)

  • Body pain symptoms

    From baseline until 1 year after baseline

  • Depression symptoms

    from baseline until 1 year after baseline

  • Physical symptoms

    from baseline until 1 year after baseline

  • Anxiety symptoms

    from baseline until 1 year after baseline

  • Sleep quality

    from baseline until 1 year after baseline

  • +4 more secondary outcomes

Study Arms (2)

Applied relaxation treatment

EXPERIMENTAL

web-based training for applied relaxation

Behavioral: Applied Relaxation

Occlusal splint

ACTIVE COMPARATOR

Occlusal splint treatment (traditional treatment)

Device: Occlusal splint

Interventions

Applied relaxation method developed by psychologists from progressive relaxation is used. The method is trained using a web application (Relappy.app), which contains step-by-step instructions with self-instructed exercises and exercise diaries, in which the examinee records his/her level of tension before and after the exercise (on a scale of 0-100, where 0 means a completely relaxed state, 50 a normal state (neither relaxed nor tense) and 100 maximum tenseness.

Applied relaxation treatment

The splint group is treated with occlusal splint, which is a conventional treatment method in cases where the implementation of information and self-care methods has not given a sufficient treatment response. The splint is prepared for night use and controlled according to the usual protocol.

Occlusal splint

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • presence of TMD pain diagnosis (myalgia, myofascial pain with referral, arthralgia and/or headache attributed to TMD), based on validated, international Diagnostic Criteria for TMD Axis I criteria
  • the patient has a full dentition (lack of a single tooth in a balanced occlusion does not preclude participation)

You may not qualify if:

  • serious general illnesses such as rheumatism, schizophrenia or other serious mental illness
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Oulu

Oulu, 90014, Finland

Location

Related Publications (7)

  • Hietaharju M, Napankangas R, Sipila K, Teerijoki-Oksa T, Tanner J, Kemppainen P, Tolvanen M, Suvinen T. Importance of the Graded Chronic Pain Scale as a Biopsychosocial Screening Instrument in TMD Pain Patient Subtyping. J Oral Facial Pain Headache. 2021 Fall;35(4):303-316. doi: 10.11607/ofph.2983.

    PMID: 34990499BACKGROUND
  • Huhtela OS, Napankangas R, Suominen AL, Karppinen J, Kunttu K, Sipila K. Association of psychological distress and widespread pain with sympatoms of temporomandibular disorders and self-reported bruxism in students. Clin Exp Dent Res. 2021 Dec;7(6):1154-1166. doi: 10.1002/cre2.472. Epub 2021 Jul 20.

    PMID: 34289266BACKGROUND
  • Hayes-Skelton SA, Usmani A, Lee JK, Roemer L, Orsillo SM. A Fresh Look at Potential Mechanisms of Change in Applied Relaxation for Generalized Anxiety Disorder: A Case Series. Cogn Behav Pract. 2012 Aug;19(3):451-462. doi: 10.1016/j.cbpra.2011.12.005.

    PMID: 23888107BACKGROUND
  • Kemani MK, Hesser H, Olsson GL, Lekander M, Wicksell RK. Processes of change in Acceptance and Commitment Therapy and Applied Relaxation for long-standing pain. Eur J Pain. 2016 Apr;20(4):521-31. doi: 10.1002/ejp.754. Epub 2015 Dec 18.

    PMID: 26684472BACKGROUND
  • Espie CA, Kyle SD, Hames P, Gardani M, Fleming L, Cape J. The Sleep Condition Indicator: a clinical screening tool to evaluate insomnia disorder. BMJ Open. 2014 Mar 18;4(3):e004183. doi: 10.1136/bmjopen-2013-004183.

    PMID: 24643168BACKGROUND
  • Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP, List T, Svensson P, Gonzalez Y, Lobbezoo F, Michelotti A, Brooks SL, Ceusters W, Drangsholt M, Ettlin D, Gaul C, Goldberg LJ, Haythornthwaite JA, Hollender L, Jensen R, John MT, De Laat A, de Leeuw R, Maixner W, van der Meulen M, Murray GM, Nixdorf DR, Palla S, Petersson A, Pionchon P, Smith B, Visscher CM, Zakrzewska J, Dworkin SF; International RDC/TMD Consortium Network, International association for Dental Research; Orofacial Pain Special Interest Group, International Association for the Study of Pain. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Groupdagger. J Oral Facial Pain Headache. 2014 Winter;28(1):6-27. doi: 10.11607/jop.1151.

    PMID: 24482784BACKGROUND
  • Huhtela OS, Koivisto N, Hagg V, Sipila K. Effectiveness of applied relaxation method vs splint in treatment of temporomandibular disorders in Finnish students. J Oral Rehabil. 2020 Feb;47(2):123-131. doi: 10.1111/joor.12884. Epub 2019 Nov 9.

    PMID: 31493297BACKGROUND

Related Links

MeSH Terms

Conditions

Temporomandibular Joint Disorders

Interventions

Occlusal Splints

Condition Hierarchy (Ancestors)

Craniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Orthotic DevicesOrthopedic EquipmentSurgical EquipmentEquipment and Supplies

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 19, 2025

First Posted

August 19, 2025

Study Start

January 8, 2024

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 31, 2030

Last Updated

September 11, 2025

Record last verified: 2025-09

Locations